EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Oxidative-Stress Biomarkers and Pathologic Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Prospective Cohort Study

Hayriye Şahinli iD, Galip Can Uyar iD, Yakup Düzköprü, Özlem Aydın İsak, Ayşe Arzu Eren, Salim Neşelioğlu iD

Cancers · 14.06.2026 · 18 (12) · 1939

DOI: 10.3390/cancers18121939 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cancers, online erschienen am 14.06.2026. Verfasst von Hayriye Şahinli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Ankara Etlik City Hospital, 06170 Ankara, Turkey. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Response to neoadjuvant chemoradiotherapy (CRT) in locally advanced rectal cancer (LARC) varies considerably, and oxidative stress may modulate radiosensitivity. This study evaluated ischemia-modified albumin (IMA) and thiol–disulfide homeostasis as potential biochemical predictors of pathological tumor regression.

Methods

A prospective observational cohort study was conducted to assess pre- and post-treatment oxidative stress biomarkers in patients with LARC receiving capecitabine-based long-course CRT. Serum IMA, native thiol, total thiol, and disulfide levels were quantified spectrophotometrically. Pathologic regression was graded according to the Modified Ryan system as good (TRG 0–1) or poor (TRG 2–3). Receiver operating characteristic (ROC) analyses, Firth-penalized logistic regression, and internal validation using cross-validation, calibration, and decision-curve analyses were performed.

Results

Of 38 screened patients, 31 met eligibility criteria and completed CRT, alongside 31 matched healthy controls. Compared with controls, patients had higher baseline disulfide (15.7 ± 5.2 vs. 11.9 ± 3.1 µmol/L; p = 0.012) and IMA levels (0.886 ± 0.062 vs. 0.798 ± 0.048 ABSU; p = 0.006). Poor responders exhibited higher pre-treatment IMA (0.927 ± 0.045 vs. 0.842 ± 0.050 ABSU; p = 0.020) and disulfide levels (18.4 ± 5.2 vs. 13.0 ± 3.8 µmol/L; p = 0.012). Pre-treatment IMA demonstrated the highest predictive accuracy for poor tumor regression (AUC = 0.872; 95% CI 0.751–0.993). In multivariable Firth-penalized logistic regression, elevated baseline IMA was independently associated with poor pathological response (OR = 3.63; 95% CI 1.22–16.20; p = 0.043), whereas negative circumferential resection margin (CRM) status was independently associated with favorable regression (OR = 0.21; 95% CI 0.02–0.71; p = 0.003). The internally validated model demonstrated excellent discrimination (AUC = 0.948; 95% CI 0.866–0.966) and good calibration.

Conclusions

Baseline IMA and CRM status were independently associated with pathological response after CRT in LARC. These findings suggest that oxidative-stress biomarkers may have potential value for response stratification; however, the results should be considered exploratory and require external validation in larger independent cohorts before clinical application.

Schlagwörter

Stichwörter der Autor:innen

chemoradiotherapyischemia-modified albümin (IMA)oxidative stressrectal cancertumor regression

Autor:innen und Institutionen

  • Department of Medical Oncology, Ankara Etlik City Hospital, 06170 Ankara, Turkey.
  • Department of Medical Oncology, Aksaray State Hospital, 68100 Aksaray, Turkey.
  • Department of Biochemistry, Ankara Etlik City Hospital, 06170 Ankara, Turkey.
  • Department of Biochemistry, Ankara Yıldırım Beyazıt University, 06370 Ankara, Turkey.

ORCID-Profile: Hayriye Şahinli, Galip Can Uyar, Salim Neşelioğlu

Zitieren

APA

Şahinli, H., Uyar, G. C., Düzköprü, Y., Aydın İsak, Ö., Eren, A. A., & Neşelioğlu, S. (2026). Oxidative-Stress Biomarkers and Pathologic Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Prospective Cohort Study. Cancers, 18(12), 1939. https://doi.org/10.3390/cancers18121939

Vancouver

Şahinli H, Uyar GC, Düzköprü Y, Aydın İsak Ö, Eren AA, Neşelioğlu S. Oxidative-Stress Biomarkers and Pathologic Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Prospective Cohort Study. Cancers. 2026;18(12):1939. doi:10.3390/cancers18121939

BibTeX
@article{ahinli2026,
  author = {Şahinli, Hayriye and Uyar, Galip Can and Düzköprü, Yakup and Aydın İsak, Özlem and Eren, Ayşe Arzu and Neşelioğlu, Salim},
  title = {Oxidative-Stress Biomarkers and Pathologic Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Prospective Cohort Study},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {12},
  pages = {1939},
  doi = {10.3390/cancers18121939}
}
Kostenlos starten →